Current Value
$140.091 Year Return
Current Value
$140.091 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPH | 74.69% | $749.28M | 0.4% |
BBH | 74.22% | $326.56M | 0.35% |
IBB | 73.21% | $5.17B | 0.45% |
FXH | 73.07% | $896.15M | 0.62% |
FHLC | 72.31% | $2.39B | 0.084% |
VHT | 72.01% | $14.85B | 0.09% |
PBE | 71.31% | $215.67M | 0.58% |
IYH | 70.62% | $2.72B | 0.39% |
MOAT | 69.22% | $12.94B | 0.47% |
XLV | 68.65% | $34.37B | 0.09% |
FBT | 68.49% | $1.00B | 0.56% |
IXJ | 67.58% | $3.75B | 0.41% |
DSTL | 67.01% | $1.88B | 0.39% |
SMOT | 66.90% | $365.00M | 0.49% |
QQQJ | 66.28% | $609.21M | 0.15% |
RSP | 66.24% | $73.23B | 0.2% |
XPH | 66.05% | $137.67M | 0.35% |
FLQM | 66.03% | $1.63B | 0.3% |
GNOM | 65.66% | $39.83M | 0.5% |
XHE | 65.45% | $170.99M | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRL | 73.71% | $6.94B | -36.62% | 0.00% |
TECH | 73.59% | $7.73B | -40.27% | 0.65% |
ICLR | 71.74% | $10.56B | -58.98% | 0.00% |
TMO | 69.02% | $156.25B | -30.32% | 0.39% |
RVTY | 68.88% | $11.12B | -15.82% | 0.30% |
A | 68.07% | $32.34B | -26.64% | 0.85% |
MTD | 68.00% | $24.09B | -23.66% | 0.00% |
MEDP | 66.36% | $8.79B | -22.98% | 0.00% |
BRKR | 64.64% | $5.73B | -50.57% | 0.53% |
DHR | 63.55% | $140.56B | -26.47% | 0.57% |
TXT | 62.12% | $13.80B | -14.15% | 0.10% |
WAT | 60.71% | $21.34B | +1.27% | 0.00% |
AZTA | 60.27% | $1.24B | -47.32% | 0.00% |
IT | 60.14% | $34.60B | -1.49% | 0.00% |
BIO | 59.59% | $6.77B | -14.81% | 0.00% |
FTV | 58.24% | $24.68B | -5.86% | 0.44% |
TRMB | 56.97% | $17.10B | +25.07% | 0.00% |
GEHC | 56.48% | $33.47B | -10.58% | 0.18% |
VLTO | 56.38% | $25.33B | +3.62% | 0.39% |
TEL | 56.12% | $48.30B | +7.37% | 1.60% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -16.07% | $46.19M | -99.95% | 0.00% |
VSTA | -8.68% | $323.21M | +12.26% | 0.00% |
LTM | -7.58% | $10.85B | -96.77% | 2.73% |
UUU | -6.84% | $4.96M | +44.93% | 0.00% |
CBOE | -6.38% | $23.50B | +22.83% | 1.09% |
MVO | -5.56% | $67.97M | -37.26% | 21.16% |
PULM | -4.39% | $23.74M | +229.95% | 0.00% |
LITB | -3.22% | $22.07M | -71.93% | 0.00% |
AIFU | -2.82% | $10.03M | -94.68% | 0.00% |
CIG.C | -2.70% | $2.46B | +5.28% | 0.00% |
MSIF | -2.65% | $753.44M | +35.28% | 6.67% |
STG | -2.51% | $28.09M | -38.64% | 0.00% |
CPSH | -1.49% | $30.36M | +19.70% | 0.00% |
MO | -1.42% | $100.17B | +29.56% | 6.73% |
K | -1.29% | $28.59B | +32.73% | 2.75% |
VSA | -1.20% | $6.80M | -46.67% | 0.00% |
BTCT | -1.14% | $26.25M | +79.76% | 0.00% |
BPT | -0.98% | $13.48M | -73.31% | 0.00% |
VRCA | 0.08% | $59.55M | -92.60% | 0.00% |
AQB | 0.35% | $3.17M | -56.89% | 0.00% |
Double maintains 9 strategies that include IQV - IQVIA Holdings, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -52.31% | $140.64M | 0.59% |
VIXY | -50.67% | $116.60M | 0.85% |
BTAL | -36.61% | $361.71M | 1.43% |
IVOL | -31.47% | $353.50M | 1.02% |
TPMN | -20.97% | $31.59M | 0.65% |
FXY | -20.36% | $850.17M | 0.4% |
FTSD | -20.14% | $212.61M | 0.25% |
XONE | -17.48% | $608.48M | 0.03% |
SPTS | -17.35% | $5.74B | 0.03% |
SHYM | -16.29% | $323.00M | 0.35% |
CLIP | -13.74% | $1.51B | 0.07% |
UTWO | -13.47% | $384.77M | 0.15% |
SCHO | -12.61% | $10.84B | 0.03% |
FXE | -12.31% | $516.25M | 0.4% |
XHLF | -12.19% | $1.46B | 0.03% |
VGSH | -12.09% | $22.36B | 0.03% |
UDN | -11.88% | $137.89M | 0.78% |
BWX | -11.26% | $1.42B | 0.35% |
IBTG | -10.97% | $1.89B | 0.07% |
IBTH | -10.78% | $1.53B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTF | -0.04% | $2.11B | 0.07% |
CMBS | -0.12% | $428.84M | 0.25% |
FLGV | -0.17% | $978.56M | 0.09% |
UTEN | 0.19% | $193.33M | 0.15% |
FLIA | -0.33% | $665.81M | 0.25% |
IBTO | 0.41% | $338.77M | 0.07% |
WEAT | -0.42% | $118.73M | 0.28% |
IEF | 0.46% | $34.36B | 0.15% |
STXT | 0.55% | $134.38M | 0.49% |
CTA | 0.56% | $1.06B | 0.76% |
JPLD | -0.58% | $1.19B | 0.24% |
SGOV | -0.84% | $45.79B | 0.09% |
FLMI | -0.92% | $662.09M | 0.3% |
CARY | 1.00% | $347.36M | 0.8% |
BSV | -1.06% | $38.28B | 0.03% |
STIP | -1.13% | $11.89B | 0.03% |
LGOV | 1.17% | $686.72M | 0.67% |
FMHI | 1.19% | $762.95M | 0.7% |
CORN | 1.40% | $49.32M | 0.2% |
TYA | -1.66% | $150.60M | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VRCA | 0.08% | $59.55M | -92.60% | 0.00% |
AQB | 0.35% | $3.17M | -56.89% | 0.00% |
CME | 0.50% | $100.16B | +31.56% | 3.79% |
HEES | 0.54% | $3.52B | +97.88% | 1.15% |
BPT | -0.98% | $13.48M | -73.31% | 0.00% |
CARV | 1.12% | $7.35M | -25.13% | 0.00% |
BTCT | -1.14% | $26.25M | +79.76% | 0.00% |
VSA | -1.20% | $6.80M | -46.67% | 0.00% |
VHC | 1.22% | $35.49M | +75.53% | 0.00% |
MKTX | 1.27% | $8.23B | +1.72% | 1.35% |
K | -1.29% | $28.59B | +32.73% | 2.75% |
ZCMD | 1.33% | $32.33M | -15.23% | 0.00% |
MO | -1.42% | $100.17B | +29.56% | 6.73% |
SRRK | 1.45% | $2.86B | +140.89% | 0.00% |
CPSH | -1.49% | $30.36M | +19.70% | 0.00% |
POAI | 1.75% | $8.93M | -40.83% | 0.00% |
DOGZ | 2.25% | $276.89M | +164.60% | 0.00% |
NEUE | 2.39% | $61.07M | +15.93% | 0.00% |
STG | -2.51% | $28.09M | -38.64% | 0.00% |
QXO | 2.63% | $9.08B | -83.77% | 0.00% |
Yahoo
Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $2.70 per share was 2.6% above analysts’ consensus estimates.
Yahoo
SCRI will contribute its community oncology knowledge and the Accelero operational model to the partnership.
Finnhub
RESEARCH TRIANGLE PARK - IQVIA , a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has announced...
Yahoo
IQVIA Holdings (NYSE:IQV) recently announced a collaboration with SCRI Development Innovations to enhance oncology trials globally. However, despite such initiatives, the company's stock price declined by 6% over the past month. This drop comes amid broader market gains, with the S&P 500 rising 4.5% in the past week. Additionally, IQVIA revised its earnings guidance upward and reported mixed Q1 2025 earnings results. These factors, while positive, didn't prevent the stock's decline,...
MarketWatch
IQVIA Holdings Inc. stock outperforms competitors on strong trading day
Yahoo
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.